Document Detail


Efficacy of recombinant-derived human superoxide dismutase on porcine left ventricular contractility after normothermic global myocardial ischemia and hypothermic cardioplegic arrest.
MedLine Citation:
PMID:  2225428     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A porcine model of normothermic global ischemia (40 minutes) followed by systemic cooling to 25 degrees C with 4 degrees C crystalloid cardioplegic arrest (90 minutes) was used to assess the efficacy of recombinant-derived human superoxide dismutase (r-HSOD) on postreperfusion left ventricular function while on cardiopulmonary bypass. Isovolumic hemodynamic function was monitored, and adenine nucleotide pool was measured in myocardial biopsy specimens and coronary sinus effluent. The treatment group of pigs (n = 7) received 15 mg/kg r-HSOD immediately before warm reperfusion, both left ventricular peak systolic pressure and developed pressure were significantly better in the r-HSOD group of pigs (p less than 0.05 vs. placebo). This improvement persisted at 60 minutes of reperfusion (p less than 0.05 vs. placebo). Myocardial ATP and total adenine nucleotides did not differ, nor did adenine nucleotide catabolites in the coronary sinus effluent differ between treatment groups of pigs. The exception to this was the nucleotide catabolite inosine, which was significantly elevated in coronary sinus effluent of pigs treated with r-HSOD at 30 minutes of reperfusion (p less than 0.05 vs. placebo). In this model of global ischemia and reperfusion, a recombinant-derived human free-radical scavenger provides significant protection of systolic but not diastolic function. Values for myocardial ATP and total adenine nucleotide content suggest that the improvement in mechanical function during reperfusion is not due to enhanced preservation of myocardial bioenergetics.
Authors:
G H Dworkin; A S Abd-Elfattah; T Yeh; A S Wechsler
Related Documents :
12124228 - A highly potent peptide analgesic that protects against ischemia-reperfusion-induced my...
19878648 - Myocardial release of fkbp12 and increased production of fkbp12.6 in ischemia and reper...
6969108 - Causes of perioperative myocardial infarction: their identification and prevention.
11181428 - Anti-apoptotic effect of benidipine, a long-lasting vasodilating calcium antagonist, in...
11385158 - Inappropriate icd therapy due to lead-related noise in an active fixation icd lead.
2035988 - Long-term results of coronary balloon angioplasty.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Circulation     Volume:  82     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1990 Nov 
Date Detail:
Created Date:  1990-12-14     Completed Date:  1990-12-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  IV359-66     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Medical College of Virginia, Richmond.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenine Nucleotides / metabolism
Adenosine Triphosphate / metabolism
Animals
Female
Free Radical Scavengers*
Heart Arrest, Induced
Humans
Male
Myocardial Reperfusion
Myocardial Reperfusion Injury / prevention & control*
Myocardium / metabolism
Recombinant Proteins / therapeutic use
Superoxide Dismutase / therapeutic use*
Swine
Time Factors
Ventricular Function, Left / drug effects*
Grant Support
ID/Acronym/Agency:
5R01 HL-26302/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Adenine Nucleotides; 0/Free Radical Scavengers; 0/Recombinant Proteins; 56-65-5/Adenosine Triphosphate; EC 1.15.1.1/Superoxide Dismutase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prolonged cardiac preservation. Evaluation of the University of Wisconsin preservation solution by c...
Next Document:  Identification of patients at greatest risk for developing major complications at cardiac surgery.